Skip to main content Skip to main navigation menu Skip to site footer

Association of Apa1 Vitamin D Receptor Polymorphism and Clinicopthological Characteristics of Breast Cancer at Sanglah Hospital Denpasar Bali

Abstract

Introduction: Cancer is one of the diseases associated with aging. Breast cancer is one of the most common cancers in women. There are many studies linking vitamin D receptor expression with breast cancer. Many previous studies have shown a significant association between the Apa1 vitamin D receptor and the clinicopathological characteristics of breast cancer. This study aims to prove the association between the Apa1 vitamin D receptor polymorphism and the clinicopathological characteristics of breast cancer at Sanglah Hospital, Denpasar Bali.

Methods: This research is an analytic study with cross sectional method. The research was conducted at the Integrated Biomedical Laboratory Unit of the Faculty of Medicine, Udayana University from February to May 2021. The samples in this study were 38 stored biological materials in the form of DNA from breast cancer patients in the Biochemistry Laboratory of the Udayana Faculty of Medicine. To determine the polymorphism of the Apa1 vitamin D receptor, DNA samples from breast cancer patients were amplified by polymerase chain reaction (PCR) method, then identified by sequencing method. Statistical analysis used bivariate and multivariate analysis to determine the association between Apa1 vitamin D receptor polymorphism and clinicopathological characteristics of breast cancer. 

Result: From the sequencing results, it was found that there were 14 people (36.8%) with homozygous Wildtype CC, 7 people (18.4%) with heterozygous AC, and 17 people (44.7%) with homozygous polymorphism AA. There was no significant association between age, menopausal status, and history of contraception with breast cancer clinicopathology, but menopausal status was significant with the stage of breast cancer patients (p=0.046). There was no significant association between the Apa1 vitamin D receptor polymorphism with the clinicopathological characteristics of breast cancer where the p value> 0.05.

Conclusion: There was no significant association between the Apa1 vitamin D receptor polymorphism with the clinicopathological characteristics of breast cancer at Sanglah Hospital, Denpasar Bali.

Section

References

  1. GLOBOCAN. Estimated age-standardized incidence rates (World) in 2020, worldwide, both sexes, all ages. 2020.
  2. Pangribowo S. Beban Kanker di Indonesia. Pus data dan Inf kemetrian Kesehat RI. 2019;8–9.
  3. Aryanti C, Setiawan IGB, Sudarsa IW. Profile of breast cancer epidemiology in Sanglah General Hospital, Denpasar, Bali from 2012 to 2019. Ann Oncol. 2019;30(November):ix11.
  4. Wihandani DM, Adiputra PAT, Supadmanaba IGP. Low prevalence of Caveolin-1 oncogenic polymorphism G14713A and T29107A among breast cancer patient in Sanglah General Hospital. Bali Med J. 2017;6(3):109.
  5. Abulkhair O, Saadeddin A, Makram O, Gasmelseed A, Pasha T, Shehata H, et al. Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia. J Steroid Biochem Mol Biol. 2016;164:106–9.
  6. El-Shorbagy HM, Mahmoud NH, Sabet S. Association of vitamin D receptor gene polymorphisms with breast cancer risk in an Egyptian population. Tumor Biol. 2017;39(10):1–9.
  7. Al-Azhri J, Zhang Y, Bshara W, Zirpoli G, McCann SE, Khoury T, et al. Tumor expression of vitamin D receptor and breast cancer histopathological characteristics and prognosis. Clin Cancer Res. 2017;23(1):97–103.
  8. Huss L, Butt ST, Borgquist S, Elebro K, Sandsveden M, Rosendahl A, et al. Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Res. 2019;21(1):1–13.
  9. Xu H, Liu Z, Shi H, Wang C. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):1–11.
  10. Gede IP, Mahayasa F, Widiana IK, Anda P, Adiputra T. Vitamin D Receptor ( VDR ) Apa1 gene polymorphism increasing the risk of breast cancer women in Bali , Indonesia. 2021;10(1):30–4.
  11. Montaser B, Gohar S, Al-Hassanin S, Soliman S. Association of Serum Vitamin D Level and Vitamin D Receptor Polymorphism (Apa 1) and Breast Cancer. Med J Cairo Univ. 2019;87(June):1515–23.
  12. Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X, et al. Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women. PLoS One. 2013;8(3).
  13. Hashemi SM, Arbabi N, Hashemi M, Mashhadi MA, Allahyari A, Sadeghi M. Association between VDR gene polymorphisms (rs 1544410, rs 7975232, rs 2228570, rs 731236 and rs 11568820) and susceptibility to breast cancer in a sample of southeastern Iranian population. Int J Cancer Manag. 2017;10(3):0–5.
  14. Kazemian, M.E. A, N. M, S. G, A.M. M, Y. J-N, et al. Vitamin D receptor genetic variation and cancer biomarkers among breast cancer patients supplemented with vitamin D3: A single-arm non-randomized before and after trial. Nutrients. 2019;11(6):1–19.
  15. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: A nested case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1856–67.
  16. Sukandar EY, Hartini S RP. Evaluasi Reaksi Obat Merugikan pada Pasien Kemoterapi Kanker Payudara di Salah Satu Rumah Sakit di Bandung. JP Farm. 2014;2(1):1–5.
  17. Kementerian Kesehatan Republik Indonesia. Infodatin Kanker Payudara. InfoDATIN. 2016. p. 1–3.
  18. Rai V, Abdo J, Agrawal S, Agrawal DK. Vitamin D receptor polymorphism and cancer: An update. Anticancer Res. 2017;37(8):3991–4003.
  19. Matini AH, Jafarian-Dehkordi N, Bahmani B, Sharifi M, Jahantigh D, Mazoochi T. Association of ApaI and TaqI polymorphisms in VDR Gene with breast cancer. Asian Pacific J Cancer Prev. 2020;21(9):2667–72.
  20. Iqbal M un N, Khan TA. Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis. Tumor Biol. 2017;39(10):1–9.
  21. Mahayasa IGPF, Widiana IK, Anda P, Adiputra T. Vitamin D Receptor ( VDR ) Apa1 gene polymorphism increasing the risk of breast cancer women in Bali , Indonesia. 2021;10(1):30–4.
  22. Kazemian E, Ekbari ME, Moradi N, Gharibzadeh S, Mondul AM, Jamshidi-Naeni Y. Vitamin D receptor genetic variation and cancer biomarkers among breast cancer patients supplemented with vitamin D3: A single-arm non-randomized before and after trial. Nutrients. 2019;11(6):1–19.
  23. Yang C, Li J, Li Y, Wu D, Sui C, Jiang Y, et al. The Vitamin D receptor gene ApaI polymorphism is associated with increased risk of renal cell carcinoma in Chinese population. Sci Rep. 2016;6(April):1–6.

How to Cite

Daniati, D., Wihandani, D. M., Darwinata, A. E., & I Gede Putu Supadmanaba. (2021). Association of Apa1 Vitamin D Receptor Polymorphism and Clinicopthological Characteristics of Breast Cancer at Sanglah Hospital Denpasar Bali. Indonesia Journal of Biomedical Science, 15(2), 217–222. https://doi.org/10.15562/ijbs.v15i2.348

HTML
98

Total
99

Share

Search Panel

Dana Daniati
Google Scholar
Pubmed
IJBS Journal


Desak Made Wihandani
Google Scholar
Pubmed
IJBS Journal


Agus Eka Darwinata
Google Scholar
Pubmed
IJBS Journal


I Gede Putu Supadmanaba
Google Scholar
Pubmed
IJBS Journal